These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10910805)

  • 21. Acute dystonia with quetiapine.
    Jonnalagada JR; Norton JW
    Clin Neuropharmacol; 2000; 23(4):229-30. PubMed ID: 11020131
    [No Abstract]   [Full Text] [Related]  

  • 22. Quetiapine for mania with Wilson's disease.
    Kulaksizoglu IB; Polat A
    Psychosomatics; 2003; 44(5):438-9. PubMed ID: 12954924
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
    Matur Z; Uçok A
    Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Rifkin AE
    J Clin Psychopharmacol; 2008 Jun; 28(3):367; author reply 368. PubMed ID: 18480708
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of quetiapine in bipolar disorder: a case series with prospective evaluation.
    Suppes T; McElroy SL; Keck PE; Altshuler L; Frye MA; Grunze H; Leverich GS; Nolen WA; Chisholm K; Dennehy EB; Post RM
    Int Clin Psychopharmacol; 2004 May; 19(3):173-4. PubMed ID: 15107662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
    Kuroki T; Kaminiwa S; Haeno M; Kohara K; Ninomiya H
    Seishin Shinkeigaku Zasshi; 2004; 106(8):1025-9. PubMed ID: 15655899
    [No Abstract]   [Full Text] [Related]  

  • 28. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of conclusions about quetiapine.
    McIntyre RS
    Am J Health Syst Pharm; 2008 Jan; 65(2):114-5; author reply 115-6. PubMed ID: 18192252
    [No Abstract]   [Full Text] [Related]  

  • 30. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Dawdy P
    J Clin Psychopharmacol; 2008 Jun; 28(3):367-8; author reply 368. PubMed ID: 18480707
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine-related tardive dyskinesia.
    Ghaemi SN; Ko JY
    Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.
    Bonafede M; Locklear JC; Wahlqvist P; Fajutrao L; Szamosi J; Pan K; Eriksson H
    J Comp Eff Res; 2015 Jan; 4(1):51-9. PubMed ID: 25168473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive pregabalin to quetiapine in acute mania.
    Oulis P; Florakis AA; Tzanoulinos G; Papadimitriou GN
    Clin Neuropharmacol; 2009; 32(3):174. PubMed ID: 19483492
    [No Abstract]   [Full Text] [Related]  

  • 36. Quetiapine monotherapy in bipolar I disorder: a 1-year stabilization in a woman having undergone bone marrow transplantation.
    Michopoulos I; Christodoulou C; Dervenoulas J; Soldatos CR; Lykouras L
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):519-21. PubMed ID: 20218807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of quetiapine for treatment-resistant bipolar disorder: a case series.
    Ghaemi SN; Katzow JJ
    Ann Clin Psychiatry; 1999 Sep; 11(3):137-40. PubMed ID: 10482123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hyperlipidemia associated with olanzapine and quetiapine use.
    Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
    Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.